Lipella Pharmaceuticals Inc.
LIPO- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001347242
No open-market purchases or sales by Lipella Pharmaceuticals Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Lipella Pharmaceuticals Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Lipella Pharmaceuticals Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Kaufman Jonathan H | See remarks below. | 898,849 | Apr 7, 2025 | 0 |
| Kim Byong | Director | – | Mar 19, 2024 | 0 |
| Pruchnic Ryan | Director | – | Mar 19, 2024 | 0 |
| Johnston Douglas | Chief Financial Officer | – | Mar 19, 2024 | 0 |
| Chancellor Michael B | Chief Medical Officer | 877,637 | Mar 19, 2024 | 0 |
| Yoshimura Naoki | Director | – | Mar 19, 2024 | 0 |
| Cohen Daniel R | Director | – | Mar 19, 2024 | 0 |
| Birder Lori | Director | – | Mar 19, 2024 | 0 |
| Battleman David S. | Director | – | Jun 21, 2023 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 15, 2024 (view filing) | May 14 | 1 day | Kaufman Jonathan HSee remarks below. | PPurchase | +10.0K | $0.76 | +$7.60K | +1.1%898.8K after | |
| Mar 19, 2024 (view filing) | Mar 18-19 | 1 day | Kaufman Jonathan HSee remarks below. | PPurchase | +55.0K | $0.8264 | +$45.5K | +6.6%888.8K after | 2 lots |